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In developing liver, cholangiocytes derive from the hepatoblasts and organize to form the bile ducts.
Earlier work has shown that the SRY-related High Mobility Group box transcription factor 9 (SOX9) is
transiently required for bile duct development, raising the question of the potential involvement of other
SOX family members in biliary morphogenesis. Here we identify SOX4 as a new regulator of cho-
langiocyte development. Liver-speciﬁc inactivation of SOX4, combined or not with inactivation of SOX9,
affects cholangiocyte differentiation, apico-basal polarity and bile duct formation. Both factors cooperate
to control the expression of mediators of the Transforming Growth Factor-β, Notch, and Hippo-Yap
signaling pathways, which are required for normal development of the bile ducts. In addition, SOX4 and
SOX9 control formation of primary cilia, which are known signaling regulators. The two factors also
stimulate secretion of laminin α5, an extracellular matrix component promoting bile duct maturation.
We conclude that SOX4 is a new regulator of liver development and that it exerts a pleiotropic control on
bile duct development in cooperation with SOX9.
& 2015 Elsevier Inc. All rights reserved.1. Introduction
In developing liver, the hepatocyte and biliary (cholangiocyte)
lineages arise from common progenitors called hepatoblasts. The
earliest biliary cells start to express the SRY-related High Mobility
Group box transcription factor 9 (SOX9) and are detected in mice
at embryonic day (E)11.5 in hepatoblasts at the vicinity of the
portal vein mesenchyme (Antoniou et al., 2009). When a growing
number of hepatoblasts differentiate to cholangiocyte precursors,
the latter progressively form the ductal plate, which is constituted
of a single layer of SOX9-positive cells surrounding the branches of
the portal vein. Primitive ductal structures (PDS) form locally
within the ductal plate around E15.5. They are detected as lumina
lined on their portal side by SOX9-positive cholangiocyte pre-
cursors and on their parenchymal side by SOX9-negativeoncy),
uclouvain.be (S. Cordi),
d Jules Bordet 121-125, 1000hepatoblasts (Antoniou et al., 2009). During maturation of PDS to
bile ducts, all cells lining the ducts acquire their typical cho-
langiocyte morphology and function. The ducts become sur-
rounded by extracellular matrix (ECM) and mesenchyme, allowing
postnatal development of hepatic artery branches (Clotman et al.,
2003; Raynaud et al., 2011a). Ductal plate cells that are not in-
volved in bile duct formation transdifferentiate and give rise to
periportal hepatocytes, and to cells lining the canals of Hering
(Carpentier et al., 2011).
A longstanding effort to characterize the mechanisms of biliary
development uncovered essential signaling pathways in cho-
langiocyte differentiation and bile duct morphogenesis (Lemaigre,
2009; Si-Tayeb et al., 2010). These include the Transforming
Growth Factor-β (TGF-β), Notch, and Yap/Hippo pathways (Clot-
man et al., 2005; Geisler et al., 2008; Tanimizu and Miyajima,
2004; Tchorz et al., 2009; Zhang et al., 2010; Zong et al., 2009). In
addition, gene knockout studies identiﬁed several transcription
factors which are required for normal biliary differentiation and
morphogenesis (Lemaigre, 2009).
We previously showed that SOX9 controls the timing of bile
duct morphogenesis. Mice with liver-speciﬁc inactivation of SOX9
show delayed maturation of PDS into bile ducts (Antoniou et al.,
2009), raising the possibility that other member of the SOX factor
family can at least partially compensate for the absence of SOX9.
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describe how it regulates bile duct development cooperatively
with SOX9.2. Materials and methods
2.1. Animals
Sox9loxP/loxP, Sox4loxP/loxP and albumin/α-fetoprotein-Cre (Alfp-
Cre) mice have been described (Kellendonk et al., 2000; Kist et al.,
2002; Penzo-Mendez et al., 2007) and were kindly provided by G.
Scherer, V. Lefebvre and F. Tronche, respectively. Experimental
protocols were approved by the Animal Welfare Committee of the
Université catholique de Louvain.
2.2. Immunodetection and histochemistry
Embryos were formalin-ﬁxed, parafﬁn-embedded and sec-
tioned at 9 μm. Sections were deparafﬁnized in xylene and rehy-
drated in graded alcohols. For antigen retrieval, sections were
microwave-heated for 10 min in 10 mM sodium citrate (pH 6.0).
Sections were permeabilized for 10 min with 0.3% Triton X-100 in
phosphate-buffered saline (PBS), blocked for 45 min with 3% milk/
10% bovine serum albumin (BSA)/0.3% Triton X-100 in PBS, and
incubated overnight at 4 °C with primary antibodies (listed in
Supplementary Table 1) diluted in 3% milk/10% BSA/0.3% Triton
X-100 in PBS. Secondary antibodies (listed in Supplementary Ta-
ble 2) were diluted 1:1000 in 10% BSA/0.3% Triton X-100 in PBS
and incubated on tissue sections for 1 h at 37 °C.
Immunodetections of Hairy and enhancer of split-1 (Hes1) and
Acetylated-Tubulin were carried out with Tyramide Signal Am-
pliﬁcation kit (#T-20935, Molecular probes, Life technologies). The
protocol was adapted for detection of laminin α5 staining: em-
bryos were gelatin-embedded after formalin-ﬁxation, and the
antigen retrieval step was omitted.
Immunohistochemical detection was performed with 3,3′-dia-
minobenzidine chromogen (DAB, #K3468, Dako) followed by
haematoxylin counterstaining.
For collagen deposit staining, tissue sections were incubated for
5 h at room temperature in picric acid solution (#92540, Sigma-
Aldrich) complemented with Fast Green dye (1 g/L) (#F7258, Sig-
ma-Aldrich) and with Direct Red 80 dye (1 g/L) (#365548, Sigma-
Aldrich).
Whole slides were scanned using the MIRAX scan system
(Zeiss). Immunoﬂuorescently-labeled sections were analysed
using a Zeiss Cell Observer Spining Disk confocal microscope. Since
bile duct development progresses from the hilum to the periphery
of the liver lobes, all analyzed sections were made near the hilum.
2.3. In situ hybridization
Embryos were ﬁxed overnight at 4 °C in ethanol 60%, for-
maldehyde 30% and acetic acid 10%, parafﬁn-embedded and sec-
tioned (9 μm). Tissue sections were deparafﬁnized in xylene and
hydrated in graded alcohols. Tissue sections were hybridized over-
night at 65 °C with digoxygenin-labeled antisense RNA probes for
Sox4 (kindly provided by V. Lefebvre), Sox9 (kindly provided by M.
Sander) and Tead2 (Jacquemin et al., 1996) diluted in hybridization
solution (formamide 50%, dextran sulfate 50% solution 20X (#S4030,
Millipore), tRNA (1 mg/mL) (#10109517001, Roche), Denhardt's so-
lution 50X (#750018, Invitrogen, Life technologies)). Tissue sections
were blocked for 1 h at room temperature in Tris buffered saline 1%
Tween 20 (TBST) complemented with blocking reagent 1.5%
(#11096176001, Roche), and incubated overnight at 4 °C with an
alkaline phosphatase-coupled antidioxygenin antibody diluted1:1500 (#11093274910, Roche), and then processed for alkaline
phosphatase activity with nitro-blue tetrazolium and 5-bromo-4-
chloro-3′-indolyphosphate (#11681451001, Roche). Whole slides
were scanned using the MIRAX scan system (Zeiss). The speciﬁcity
of the in situ hybridization probes was validated previously (Dy
et al., 2008; Jacquemin et al., 1996; Lioubinski et al., 2003). Since bile
ducts develop according to a hilum-to-periphery axis, several duct
maturation levels can be monitored in a single lobe at a single de-
velopmental stage. Therefore, during development, the most mature
ducts located near the hilum were analyzed.
2.4. Cell culture
Sox4loxP/loxP; Sox9loxP/loxP females were mated with Sox4loxP/loxP;
Sox9loxP/loxP; Alfp-Cre males. E12.5 embryos were dissected and
genotyped. Livers were collected and cell-dissociated in RMPI
(#31870-025, Gibco, Life technologies) containing collagenase IV
(1 mg/mL) (#43E14253, Worthington), dispase (1 mg/mL)
(#17105-041, Gibco, Life technologies) and DNase I (0.1 mg/mL)
(#11284932001, Roche). Cells were resuspended in 40 μl of EDTA
2 mM, 0.5% BSA in PBS (MACS buffer) and incubated with 2 μl goat
biotinylated anti-Dlk1 antibody (# BAF1144, R&D systems) for
10 min at 4 °C to isolate Dlk1-positive hepatoblasts. After washing
with PBS, cells were resuspended in 80 μl of MACS buffer, and
20 μl of anti-biotin microbeads (#120-000-900, Miltenyi) were
added followed by 15 min incubation at 4 °C. After washing with
MACS buffer, Dlk1-positive hepatoblasts were puriﬁed using a
magnetic column (#130-042-201, Miltenyi), plated in 24-well
plates coated with collagen (#08-115, Millipore) (50.000 cells/
well) and cultured for 72 h in RPMI supplemented with 10% fetal
bovine serum (#F6178, Sigma-Aldrich), EGF (50 ng/mL) (#AF-100-
15, Peprotech), ITS 100X (#41400-045, Gibco, Life technologies)
and IGF-II (30 ng/mL) (#100-12, Peprotech). Total RNA was ex-
tracted and gene expression was quantiﬁed by RT-qPCR with pri-
mers listed in Supplementary Table 3. Data were normalized to β-
actin values.
2.5. Biliary tree casting
Six- to eight-week-old mice were euthanized. Ink (Drawing ink
A, Pelikan, Germany) was injected in canulated common bile duct
(Walter et al., 2012). The entire liver was removed, formalin-ﬁxed
and clariﬁed in a 1:2 solution of benzyl alcohol and benzyl
benzoate.
2.6. Serum analysis
Blood was collected from 6- to 8-week-old mice and serumwas
analyzed using reagents for total and direct bilirubin (#442745,
#439715, synchron LX (clinical system, Beckman Coulter).
2.7. Liver RNA analysis
Wild-type and mutant livers were collected. Total liver RNA
was isolated using Trizol (#10296028, Invitrogen, Life technolo-
gies) and gene expression was quantiﬁed by RT-qPCR with primers
listed in Supplementary Table 3. mRNA levels were normalized
with β-Actin mRNA.
2.8. Primary cilia quantiﬁcation
Confocal pictures of acetylated tubulin-stained sections were
used to quantify the number of primary cilia at the apical pole of
ductal cells in E18.5 fetal livers. The number of ductal cells positive
for acetylated tubulin staining was normalized to the number of
ductal cells delineating bile ducts. Three animals were analyzed
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animal.3. Results
3.1. Biliary-speciﬁc expression of SOX4 in developing liver
The mild and transient biliary phenotype resulting from the
lack of SOX9 in liver (Antoniou et al., 2009), combined with the
known redundancy of SOX factors in cell differentiation (Kamachi
and Kondoh, 2013), suggested that other SOX factors control bili-
ary development. RT-qPCR analysis of RNA from total developing
liver detected mRNA of several SOX factors (data not shown), and
in situ hybridization experiments identiﬁed SOX4 as the most
promising candidate for regulation of biliary development. Indeed,
SOX4 was detectable in the ductal plate and developing bile ducts
starting at the onset of biliary development (E12.5; Fig. 1A). SOX4Fig. 1. SOX4 and SOX9 expression in the developing liver. (A) In situ hybridization in WT
at E12.5. (B) Adjacent tissue sections show overlapping expression of SOX4 and SOX9 in b
but persists in periportal and scattered parenchymal cells; the latter are likely not deriv
other. mes, mesenchyme; dp, ductal plate; bd, bile duct. Size bar, 100 μm.was also expressed in the portal mesenchyme and in rare scattered
parenchymal cells; the latter did not belong to the hepatic lineage
(see below). Except for the expression in the portal mesenchyme
and parenchymal cells, SOX4 expression overlapped with that of
SOX9 (Fig. 1B). This expression proﬁle prompted us to investigate
the function of SOX4 and to evaluate potential redundancy be-
tween SOX4 and SOX9 in biliary development.
For this purpose, we inactivated ﬂoxed Sox4 and/or Sox9 alleles
(Kist et al., 2002; Penzo-Mendez et al., 2007) in developing liver
using Cre recombinase driven by albumin and α-fetoprotein gene
regulatory regions (Alfp-Cre). This approach enables gene in-
activation in hepatoblasts at the onset of biliary development
which starts at E11.5–E13.5 (Antoniou et al., 2009). Combined
deletion of Sox4 and Sox9 was also performed. The efﬁciency of
Sox4 gene inactivation was controlled by in situ hybridization:
Sox4loxP/loxP;Alfp-Cre embryos (Sox4ko) showed inactivation of
Sox4 in the developing cholangiocytes at E13.5 (Fig. 1B and S1),
while periportal and parenchymal SOX4 expression was notlivers shows SOX4 mRNA expression in portal mesenchyme and biliary cells starting
iliary cells. In Alfp-Cre;Sox4loxp/loxp (Sox4ko) embryos, SOX4 is deleted in biliary cells
ed from hepatoblasts. Inactivation of Sox4 or Sox9 did not affect expression of the
Fig. 2. Cholangiocyte differentiation is perturbed in the absence of SOX4 and SOX9. (A) At E15.5, immunostaining shows residual expression of HNF4 in the portal side of
Sox4ko and Sox9ko PDS (yellow arrows) as well as reduced expression of HNF6. In Sox4/Sox9ko, HNF6 and HNF1β expression was not detected while HNF4 persisted in all
PDS cells. (B) In Sox4ko and Sox9ko at E18.5, asymmetrical bile ducts show persistent expression of HNF4 and low expression of HNF1β in cells mostly located on the
parenchymal side (white arrows); this phenotype is worsened in Sox4/Sox9ko. HNF6 expression was normalized in Sox4ko and Sox9ko but remained low in a subset of Sox4/
Sox9ko cells (white arrows). Ecad; E-cadherin; pv, portal vein; *, lumen of developing bile ducts. White size bar, 25 μm; yellow size bar, 100 μm.
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activation starting at E11.5 (Antoniou et al., 2009). Inactivation of
either Sox gene did not affect expression of the other (Fig. 1B and
Fig. S1).
3.2. SOX4 and SOX9 control cholangiocyte differentiation
PDS are detected in wild-type embryos starting at E15.5, and
are lined by cells expressing the hepatoblast marker Hepatocyte
Nuclear Factor 4 (HNF4) on the parenchymal side and HNF1βFig. 3. The lack of SOX4 or SOX9 induces transient defects in bile duct development,
Immunostaining at P6 shows normal expression of the differentiation markers HNF4 an
hepatocyte characteristics, as shown by expression of HNF4 and carbamoyl phosphate
synthase (GS) was normal and strictly pericentral. β-cat, β-catenin (used as epithelial m
central vein; *, lumen of bile ducts. White size bar, 25 μm; yellow size bar, 100 μm. Th
mesenchyme.predominantly on the portal side. The absence of SOX4 or SOX9 in
single knockouts only induced limited differentiation defects at
that stage, namely residual expression of HNF4 in some cells lining
the portal side of PDS, lower expression of HNF6 in differentiating
cholangiocytes, and normal HNF1β levels on the portal side of the
PDS (Fig. 2A). In contrast, the combined inactivation of both factors
(Sox4loxP/loxP;Sox9loxP/loxP;Alfp-Cre (Sox4/Sox9ko)) strongly per-
turbed biliary differentiation and this was observed in nearly all
analysed ducts: biliary markers (HNF6, HNF1β) were barely de-
tectable and expression of the hepatoblast marker HNF4 persistedwhile combined absence of both factors is associated with persisting anomalies.
d HNF6 in Sox4ko and Sox9ko livers. Duct-lining cells in Sox4/Sox9ko liver display
synthase I (CPSI), and low levels of HNF6 (white arrows). Expression of glycogen
arker); CK, pan-Cytokeratin; pv, portal vein; mes, mesenchyme; bd, bile duct; cv,
e yellow dotted line delineates the boundary between hepatocytes and periportal
A. Poncy et al. / Developmental Biology 404 (2015) 136–148 141in cells lining small-sized lumina (Fig. 2A). These data were in line
with our observations on hepatoblasts puriﬁed from E12.5 livers.
Indeed, when these hepatoblasts were FACS-sorted based on Dlk1
expression (Tanimizu et al., 2003) and grown in conditionsFig. 4. Six-week-old mice with liver-speciﬁc inactivation of SOX4 and SOX9 are chole
means7SD; n¼ 6; **po0.01, ***po0.001). (B) Septal ﬁbrosis and ductular reactions d
retrograde injection of ink reveals truncated and dilated hilar ducts (arrows), and ductula
central vein, FG, Fast green. White size bar, 200 μm; yellow size bar, 50 μm.promoting biliary gene expression, biliary genes were upregulated
and hepatocyte markers were decreased after 72 h of culture. In
contrast, hepatoblasts puriﬁed from Sox4/Sox9ko livers showed
lower biliary gene induction and lower repression of hepatocytestatic. (A) Serum levels of bilirubin are increased in Sox4/Sox9ko mice (data are
evelop as a result from cholestasis caused by abnormal development of bile ducts:
r reactions connected with the hilar ducts (arrowheads in inset). pv, portal vein; cv,
A. Poncy et al. / Developmental Biology 404 (2015) 136–148142markers (Fig. S2).
Later, at the end of gestation (E18.5), wild-type PDS had ma-
tured to generate bile ducts symmetrically lined by differentiated
cholangiocytes (Fig. 2B). In contrast, Sox4ko, Sox9ko and Sox4/
Sox9ko cholangiocyte differentiation was still perturbed at E18.5.
This was illustrated by the persisting expression of HNF4 on the
parenchymal side of the bile ducts in Sox4ko and Sox9ko, and in
all cells lining the lumen in Sox4/Sox9ko. Also, HNF1β expression
was low in a signiﬁcant proportion of biliary cells (mainly on the
parenchymal side of ducts) in livers deﬁcient in SOX4 or SOX9, and
was barely detectable in double Sox4/Sox9ko knockouts, as com-
pared to wild-type. At E18.5 HNF6 had returned to normal in
Sox4ko and Sox9ko biliary cells but was persistently low in a
subset of Sox4/Sox9ko duct-lining cells (Fig. 2B).
After birth at P6, cholangiocyte differentiation had returned to
normal in Sox4ko and Sox9ko livers, as shown by the expected
downregulation of HNF4 and normal expression of HNF6 in cho-
langiocytes (Fig. 3). Therefore, the absence of SOX4 alone led to
delayed cholangiocyte differentiation, as found earlier in the ab-
sence of SOX9 (Antoniou et al., 2009). In contrast, Sox4/Sox9ko
mice showed persistent and pronounced biliary differentiation
defects. In the absence of the two SOX factors, high levels of the
hepatoblast/hepatocyte marker HNF4 were detected in cells lining
lumina and HNF6 expression was low. In addition, these cells
displayed characteristics of periportal hepatocytes as indicated by
detection of carbamoyl phosphate synthase I (CPS1), an enzyme
normally expressed in zone 1 and 2 hepatocytes (Christoffels et al.,
1999). Glutamine synthase, an enzyme of perivenous hepatocytes
was not expressed in the cells lining lumina (Fig. 3).
Single and double knockout mice survived well. Six-week-old
adult Sox4/Sox9ko mice were cholestatic, as shown by the high
levels of serum bilirubin (Fig. 4A). This was associated with liver
ﬁbrosis and ductular reactions characterized by luminal structures
lined by cells expressing high levels of cytokeratin (pan-cytoker-
atin immunostaining), and variable levels of HNF4 (Fig. 4B). Ret-
rograde injection of ink in the biliary tree demonstrated that the
bile ducts had not developed properly: hilar ducts appeared di-
lated and truncated and diffusion of ink into small-sized channels
indicated that the lumina of ductular reactions were connected to
the hilar ducts.
We concluded that SOX4 and SOX9 individually control the
timing of cholangiocyte differentiation and that they are co-
operatively required for cholangiocyte differentiation.
3.3. SOX factors control polarity of cholangiocytes
Polarization and differentiation are coordinated in epithelia
(Kesavan et al., 2009) and are essential for cholangiocyte function.
Therefore, we investigated the acquisition of polarity in biliary
cells in SOX-mutant biliary cells.
In developing liver, the apical markers Osteopontin (OPN) and
Mucin-1 (Muc) became detectable at the apical pole of wild-type
PDS cells starting at E15.5. In single knockouts OPN was initially
cytoplasmic (Sox4ko) or nearly undetectable (Sox9ko) at E15.5 but
became detectable at the apical pole at the end of gestation (E18.5;
Sox4ko and Sox9ko); Mucin-1 was apical, as expected, but very
low in a subset of cells at E18.5 (Sox4ko and Sox9ko). RT-qPCR data
on whole liver at E18.5 further conﬁrmed these observations, and
showed that OPN expression was mainly controlled by SOX9, and
Muc1 by SOX4 (Fig. 6A). In contrast, the lack of both SOX factors
was associated with absence of apical polarization during gesta-
tion (Figs. 5–6A).
In the postnatal period (P6), polarization of SOX9-deﬁcient li-
vers progressively normalized (Fig. 5), conﬁrming our earlier ob-
servations (Antoniou et al., 2009). In contrast, in the absence of
SOX4, polarity remained perturbed postnatally (Fig. 5): at theapical pole OPN was mislocalized, Mucin-1 was absent at the
apical pole of most cells, and a subset of cells did not show Ezrin
expression; at the basal pole, laminin expression was fragmented.
In addition, SOX4-deﬁcient biliary cells were no longer cuboidal
but instead displayed an irregular cobblestone-like shape. Im-
portantly, the combined absence of SOX4 and SOX9 was associated
with major polarity defects: apical markers (OPN, Mucin-1, Ezrin)
and basal markers (pan-laminin) were not detected and cell
morphology was irregular; pan-cytokeratin staining further in-
dicated that the cytoskeleton was disrupted (Fig. 5).
Therefore, SOX4 is essential to establish apico-basal polarity
and cell morphology, whereas SOX9 is only transiently required for
polarization; both factors cooperate to set up apico-basal polarity.
3.4. SOX4 and SOX9 control signaling pathways involved in biliary
development
Cholangiocyte differentiation and bile duct morphogenesis are
induced by a combination of intercellular signaling pathways, the
best characterized being TGF-β, Notch, and Hippo pathways. SOX4
and SOX9 are known regulators of these pathways in cancer and
development (Bhattaram et al., 2010; Delous et al., 2012; Kuwa-
hara et al., 2012; Manfroid et al., 2012; Moreno, 2010; Scharer
et al., 2009; Song et al., 2013; Vervoort et al., 2013), raising the
possibility that SOX factors control biliary development by mod-
ulating the response to intercellular signaling. To address this
hypothesis, we investigated the expression of signaling markers in
SOX factor-deﬁcient livers.
Transforming growth factor β receptor II (TβRII) mediates the
TGF-β response in developing hepatoblasts (Clotman et al., 2005;
Takayama et al., 2014). When the hepatoblasts are stimulated by
TGF-β the cells differentiate to the cholangiocyte lineage in which
ΤβRII then becomes repressed (Antoniou et al., 2009). Therefore,
in wild-type developing ducts, repression of TβRII is a mark of
previously active TGF-β signaling: at E15.5 TβRII was repressed on
the portal side of PDS, but still detectable on their parenchymal
side; at E18.5, when ducts have matured, TβRII was no longer
detected in cholangiocytes (Fig. 7). In the absence of SOX4 and/or
SOX9, TβRII was not repressed on the portal side of PDS at E15.5.
At E18.5, TβRII is normally repressed in Sox9ko cholangiocytes
while it was still detected in some duct cells in the absence of
SOX4 and in double knockouts (Fig. 7). These TβRII-positive cells in
the Sox4ko ducts belonged to the cholangiocyte lineage since they
were HNF4-negative (Fig. 7). This was in line with our observa-
tions on cultured Sox4/Sox9ko hepatoblasts: when grown in cul-
ture as above, expression of TβRII and of PAI-1, a TGF-β signaling
target, increases in the absence of SOX4 and SOX9 (Fig. S2). These
data indicate that SOX4 and SOX9 control TGF-β signaling early in
biliary development.
Notch signaling is critical in biliary development and Hes1 in-
duction is a marker of active Notch signaling. The absence of SOX4
and/or SOX9 did not affect Hes1 expression at E15.5 (Fig. S3A).
However, at E18.5 Hes1 was detected at lower levels in most SOX-
mutant cells as compared to wild-type cells (Fig. 7). Abnormal
Hes1 expression persisted postnatally in the combined absence of
SOX4 and SOX9 (Fig. S3A). Therefore, SOX4 and SOX9 control
Notch signaling in developing biliary cells, but this effect was
detectable at a later stage than that on TGF-β signaling.
The Hippo-Yap pathway is required for biliary development,
and Tead2, the main co-activator of Yap, is a direct target of SOX4
in neural and mesenchymal progenitors (Bhattaram et al., 2010;
Zhang et al., 2010). We found that Yap is predominantly expressed
in biliary cells. Yap expression did not differ signﬁcantly in wild-
type and Sox mutant mice (Fig. S3B). However, Tead2 expression,
which is speciﬁcally detected in biliary cells, depended on SOX4
but not on SOX9: Tead2 was low in Sox4ko and Sox4/Sox9ko livers,
Fig. 5. SOX factors control polarity of cholangiocytes. Immunostaining shows downregulation of apical polarity markers Osteopontin (OPN) and Mucin1 (Muc) in Sox4ko and
Sox9ko at E15.5 and E18.5; cell-to-cell variability was observed in the level of OPN and Mucin1 downregulation. Polarity marker expression normalizes after birth (P6) in
Sox9ko, but not in Sox4ko ducts which display mislocalization of OPN, downregulation of Mucin1 and Ezrin at the apical pole in a subset of cells (arrows), as well as
fragmented laminin (Lam) staining at the basal pole. In Sox4/Sox9ko, all polarity markers were absent or barely detected at all stages tested. Cell morphology is perturbed as
shown by pan-cytokeratin (CK) staining in Sox4ko and Sox4/Sox9ko. Ecad, E-cadherin; pv, portal vein; mes, mesenchyme; *, lumen of bile ducts. Size bar, 25 μm.
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Fig. 6. SOX factors control the expression of polarity and signaling markers, and
development of primary cilia. (A) Expression of polarity and (B) signaling markers,
measured by RT-qPCR in whole livers at E18.5 (data are means7SEM; n¼6 animals
per genotype; *po0.05, **po0.01, ***po0.001). (C) Quantiﬁcation of primary cilia
on duct-lining cells at E18.5 (data are means7SEM; n¼3 animals per genotype;
**po0.01, ***po0.001. From 227 to 420 ductal cells were counted per genotype).
A. Poncy et al. / Developmental Biology 404 (2015) 136–148144but not in Sox9ko livers (Figs. 6B and 7). This was also seen in
cultured hepatoblasts deﬁcient in SOX4 and SOX9 (Fig. S2). When
we analyzed the expression of Hippo/Yap signaling markers Ctgf,
Cyr61 and Amotl2 (Yimlamai et al., 2014), we found that in-
activation of either of the two SOX factors had no signiﬁcant im-
pact, but that two of the markers were downregulated in the
combined absence of SOX4 and SOX9 (Fig. 6B). We concluded that
the SOX factors may participate to the regulation of Hippo sig-
naling, but that this does not seem to be critical for SOX factor
function.
The apical pole of cholangiocytes has a primary cilium, and
ciliary defects are associated with perturbed biliary development
(Raynaud et al., 2011b). In addition, cilia integrate several signaling
pathways required for biliary development such as Notch, TGF-β
and Hippo pathways (Clement et al., 2013; Habbig et al., 2011;
Leitch et al., 2014). Cilia were detected by staining for acetylated
tubulin in livers deﬁcient in SOX4 or SOX9 at prenatal and post-
natal stages (Fig. 7 and Fig.S3A). In contrast, the combined absence
of SOX4 and SOX9 prevented prenatal development of cilia, and
led to a reduced number of cilia postnatally (Figs. 6C, 7 and S3A),
suggesting that aberrant cilium development further contributes
to abnormal bile duct development.
The ECM surrounding developing bile ducts contains laminin
α1 and α5. While laminin α1, produced by adjacent ﬁbroblasts, is
essential to establish apicobasal polarity in cholangiocytes, lami-
nin α5 is secreted by biliary cells and is required for maturation of
the ducts (Tanimizu et al., 2012). Laminin α1 was not affected by
the absence of SOX factors. In contrast, in single and double
knockouts laminin α5 was lacking along the parenchymal side of
bile ducts (Fig. 7). The lack of laminin α5 in the absence of SOX
factors is further expected to induce deﬁcient bile duct
development.
We conclude that SOX4 and SOX9 cooperatively control bile
duct development and that their expression is required for normal
expression of mediators of TGF-β, Notch, and Hippo signaling. In
addition, cilia formation at the apical pole and secretion of laminin
α5 at the basal pole, two processes involved in normal duct
morphogenesis, are also dependent on SOX factors.4. Discussion
In previous work, we have shown that SOX9 is one of the
earliest and most speciﬁc biliary markers. The analysis of SOX9-
deﬁcient livers revealed that this factor controls the timing of bile
duct development (Antoniou et al., 2009). Here, we found that
SOX4 is also expressed in developing cholangiocytes; its in-
activation delays biliary differentiation and is associated with de-
ﬁcient apico-basal polarity and perturbed cell morphology. In
addition, the two factors cooperate in bile duct development, since
their combined absence inhibits differentiation, polarization and
bile duct morphogenesis. Analysis of signaling effectors and
mediators in SOX4- and SOX9-deﬁcient livers suggest that the two
factors modulate the function of several pathways required for bile
duct development.
SOX4 and SOX9 belong to distinct groups of the SOX family,
called SoxC and SoxE, respectively (Lefebvre et al., 2007). The SoxC
group consists of SOX4, SOX11 and SOX12. In situ hybridization of
SOX11 did not reveal expression in biliary cells, and SOX12 mRNA
levels in total liver were one order of magnitude lower than those
of SOX4 (data not shown). The SoxE group consists of SOX8, SOX9
and SOX10. mRNAs of SOX8 and SOX10 were only detected at
marginal levels in developing liver by qRT-PCR, and were not
considered for further investigation. Therefore, SOX4 and SOX9
stood out in developing livers as candidate regulators of biliary
development.
SOX factors co-regulating a developmental process often be-
long to the same group. There are exceptions such as the SoxD
proteins SOX5/SOX6 and the SoxE protein SOX9, known as the
"Sox trio", which cooperate to control chondrogenesis (Kamachi
and Kondoh, 2013; Lefebvre et al., 2007). To our knowledge, biliary
development is the ﬁrst biological process coregulated by a "Sox
duo" composed of SOX4 and SOX9.
Combined absence of SOX4 and SOX9 affected several signaling
pathways known to control biliary development. Therefore, it is
unlikely that the knockout phenotype depends on a small set of
genes directly regulated by the two factors. Rather, our data sug-
gest that SOX4 and SOX9 exert a combination of pleiotropic and
indirect effects on bile duct development. When considering the
timing of the Sox4/Sox9ko phenotype, abnormal TGF-β signaling
appears as an initiating event. At E15.5, expression of TβRII per-
sists in all Sox4/Sox9ko cells lining lumina and the cells display
increased TGF-β signaling as evidenced by increased PAI-1 ex-
pression. Interestingly, HNF6 is a known repressor of TβRII ex-
pression (Clotman et al., 2005; Plumb-Rudewiez et al., 2004) and
increased expression of TβRII in Sox4/Sox9ko cells in vivo and in
vitro correlates with decreased levels of HNF6. These data suggest
that regulation of HNF6 by SOX4 and SOX9 is a key process in
biliary differentiation (Fig. 8).
Reduced expression of Hes1 in developing duct cells unveils
perturbed Notch signaling. Abnormal Hes1 expression in the ab-
sence of SOX4 and SOX9 is detected at E18.5, i.e. at a later stage
than abnormal TβRII expression. This raises the possibility that
perturbed Notch signaling is a consequence of abnormal initiation
of biliary development. We note that Hes1 expression, like HNF1β
expression, is predominantly reduced at the parenchymal side of
ducts. This suggests that aberrant Hes1 and HNF1β expression
reﬂects deﬁcient maturation of the parenchymal side of the ducts.
Since Notch signaling functions by cell–cell contact, aberrant
Notch signaling may cause cell-to-cell variability in gene expres-
sion. This may contribute to the cell-to-cell variability in expres-
sion of proteins such as Ezrin, HNF1β or HNF6.
Furthermore, Notch activation induces Hes1 and SOX9, and
promotes biliary morphogenesis (Kodama et al., 2004; Zong et al.,
2009). Moreover, in developing pancreas, SOX9 regulates Hes1,
raising the possibility that SOX9 modulates Hes1 activity in bile
Fig. 7. SOX factors control signaling pathways involved in biliary development. At E15.5, TβRII is repressed on the portal side of PDS in wild-type livers but persists in all PDS
cells of knockout mice. At E18.5, TβRII is downregulated in wild-type ducts but still detectable in a subset of cells lining Sox4ko (white arrows) and Sox4/Sox9ko ducts. In the
absence of SOX4 and/or SOX9, Hes1 is low or absent from cholangiocytes. Tead2 is expressed in the ductal plate and portal mesenchyme (in situ hybridization) and biliary-
speciﬁc expression depends on SOX4. Cilia (acetylated tubulin; AcTub) are absent in Sox4/Sox9ko ducts. Laminin α5 (Lamα5) staining surrounds bile ducts of wild-type mice
while its expression is absent from to the parenchymal side of bile ducts in Sox4ko, Sox9ko and Sox4/Sox9ko livers. Ecad, E-cadherin; pv, portal vein; dp, ductal plate; mes,
mesenchyme; *, lumen of bile ducts. White size bar, 25 μm; black size bar, 200 μm.
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Fig. 8. Schematic overview of gene interactions operating during differentiation of hepatoblasts to cholangiocytes. The scheme integrates data from references Clotman et
al. (2005, 2002), Geisler et al. (2008), Hunter et al. (2007), Krupczak-Hollis et al. (2004), Ludtke et al. (2009), Oikawa et al. (2009), Rogler et al. (2009), Takayama et al. (2014),
Tanimizu and Miyajima (2004), Tanimizu et al. (2007), Tchorz et al. (2009), Zhang et al. (2010), Zong et al. (2009).
A. Poncy et al. / Developmental Biology 404 (2015) 136–148146ducts (Seymour et al., 2007; Shih et al., 2012). Similarly, SOX4
activates Notch signaling in prostate cancer (Moreno, 2010) sug-
gesting that this factor may exert similar functions in cholangio-
cytes. Therefore, direct effects of SOX4 and SOX9 on Notch sig-
naling mediators cannot be excluded in biliary development.
Along the same lines, primary cilia are absent at the apical pole of
cholangiocytes in liver in combined absence of SOX4 and SOX9.
Since primary cilia can modulate Notch and TGF-β signaling
(Clement et al., 2013; Leitch et al., 2014), we suggest that altered
ciliary function may secondarily contribute to deﬁcient bile duct
development via perturbed Notch and TGF-β signaling.
The YAP co-activator Tead2 is controlled by SOX4, but does not
require SOX9. Importantly, downregulation of Tead2 in Sox4ko
liver is neither associated with changes in the nuclear localization
of YAP, nor with downregulation of YAP target genes. This raises
the possibility that other Tead proteins compensate for the re-
duced levels of Tead2. Livers doubly deﬁcient in SOX4 and SOX9
show reduced levels of a subset of Hippo signaling markers,
without anomaly of nuclear YAP location. This raises the possibi-
lity that SOX factors regulate Hippo signaling during bile duct
development, but our data do not support that a SOX-Hippo cas-
cade is a master regulator of biliary development.
Perturbed laminin deposition may contribute to the biliary
phenotype of Sox4/Sox9ko mice. Indeed, SOX9 is required for ac-
tivation of ECM genes and for laminin deposition (Hanley et al.,
2008; Lincoln et al., 2007; Rockich et al., 2013), and laminins
regulate the development of bile ducts (Tanimizu et al., 2012).
Laminin expression was delayed in the absence of SOX9, perma-
nently fragmented in the absence of SOX4, and missing in the
absence of both factors (Fig. 5). Thus, the level of laminin deﬁ-
ciency correlates well with the severity of the biliary phenotype in
Sox9ko, Sox4ko and Sox4/Sox9ko mice. In addition, laminins reg-
ulate apico-basal polarity (Tanimizu et al., 2007), suggesting that
abnormal polarity in SOX-deﬁcient livers results from the reduced
levels of laminin α5 at the basal pole. Abnormal polarity may in
turn affect partitioning of cytoskeletal proteins such as cytoker-
atins whose intracellular distribution is strongly affected in the
absence of both SOX4 and SOX9.
In adult animals, the absence of SOX4 and SOX9 is associated
with deﬁcient development of peripheral bile ducts, butpersistence of dilated hilar ducts. This observation suggests that
the cholangiocytes lining hilar and peripheral ducts belong to
distinct subtypes. Whether this reﬂects a distinct embryonic origin
cannot be determined. Intrahepatic cholangiocytes derive from
hepatoblasts, while extrahepatic cholangiocytes derive from a di-
verticulum of the endoderm. Where the intra- and extrahepatic
ducts fuse is not known, and we cannot eliminate the possibility
that the persisting hilar ducts in Sox4/Sox9ko liver derive from
extrahepatic ducts. In any case, these hilar ducts were deﬁcient in
SOX factors (not shown).
Ductular reactions were detected in adult Sox4/Sox9ko liver.
This is most likely induced by chronic cholestasis, but the origin of
the ductular reactive cells has not been determined. Such cells
may derive from the biliary tract or from hepatocytes. We favor
the hypothesis that they derive from hepatocytes since most
ductular reactive cells express the hepatocyte marker HNF4.
To conclude, we found that SOX factors cooperate to regulate
bile duct development and propose that they are integrated in the
biliary gene network (Fig. 8) and exert pleiotropic effects on po-
larity, differentiation and morphogenesis. These effects are in-
itiated by regulation of TGF-β signaling by the SOX factors. Our
work is relevant to improve and validate the in vitro production of
pluripotent stem cells into cholangiocytes and for potential cell
therapy of biliary disease.Acknowledgments
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